Teachers Retirement System of The State of Kentucky Cuts Stake in West Pharmaceutical Services, Inc. (NYSE:WST)

Teachers Retirement System of The State of Kentucky cut its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 4.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,500 shares of the medical instruments supplier’s stock after selling 235 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in West Pharmaceutical Services were worth $2,335,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC boosted its stake in West Pharmaceutical Services by 41.3% in the first quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock worth $88,000 after buying an additional 232 shares in the last quarter. Rafferty Asset Management LLC lifted its stake in West Pharmaceutical Services by 9.1% in the second quarter. Rafferty Asset Management LLC now owns 1,722 shares of the medical instruments supplier’s stock worth $618,000 after acquiring an additional 144 shares during the period. Rockefeller Capital Management L.P. lifted its stake in West Pharmaceutical Services by 79.4% in the second quarter. Rockefeller Capital Management L.P. now owns 6,988 shares of the medical instruments supplier’s stock worth $2,509,000 after acquiring an additional 3,093 shares during the period. Van ECK Associates Corp raised its holdings in West Pharmaceutical Services by 15.4% in the second quarter. Van ECK Associates Corp now owns 9,079 shares of the medical instruments supplier’s stock worth $3,260,000 after purchasing an additional 1,213 shares in the last quarter. Finally, BNP Paribas Arbitrage SA raised its holdings in West Pharmaceutical Services by 10.2% in the second quarter. BNP Paribas Arbitrage SA now owns 28,133 shares of the medical instruments supplier’s stock worth $10,103,000 after purchasing an additional 2,596 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

WST stock opened at $379.78 on Friday. West Pharmaceutical Services, Inc. has a twelve month low of $253.85 and a twelve month high of $475.35. The company has a quick ratio of 2.23, a current ratio of 2.86 and a debt-to-equity ratio of 0.10. The stock has a market cap of $28.13 billion, a P/E ratio of 47.12, a PEG ratio of 1.61 and a beta of 0.97. The business’s 50-day moving average price is $432.73 and its 200-day moving average price is $423.62.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, October 28th. The medical instruments supplier reported $2.06 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.26. West Pharmaceutical Services had a return on equity of 30.35% and a net margin of 22.85%. The business had revenue of $706.50 million for the quarter, compared to the consensus estimate of $687.09 million. During the same quarter in the previous year, the company posted $1.15 EPS. The company’s revenue was up 28.9% compared to the same quarter last year. On average, equities research analysts expect that West Pharmaceutical Services, Inc. will post 8.49 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 2nd. Investors of record on Wednesday, January 19th will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend is Tuesday, January 18th. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 8.93%.

Separately, Zacks Investment Research downgraded West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $450.00 price target for the company. in a report on Saturday, January 8th.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.

Featured Article: What is a Real Estate Investment Trust (REIT)?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.